Actively Recruiting
68Ga-DOTATATE Neuroblastoma Imaging Pilot
Led by Centre de recherche du Centre hospitalier universitaire de Sherbrooke · Updated on 2024-08-23
20
Participants Needed
3
Research Sites
303 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Neuroblastoma is the most frequent extracranial childhood tumor, with an annual incidence of approximately 10.2 per million children. Staging of the disease can be done by different imaging strategies (CT, MRI, scintigraphy and PET/CT). Discrepancies may be observed among these different strategies resulting in different treatment strategies. The goal of this study is to assess the feasibility and safety of 68Ga-DOTATATE and to compare it to 123I-MIBG when investigating neuroblastoma.
CONDITIONS
Official Title
68Ga-DOTATATE Neuroblastoma Imaging Pilot
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Newly suspected or biopsy-proven neuroblastoma or recurrence of neuroblastoma
- Planned 123I-MIBG imaging
- Able and willing to provide signed informed consent in French or English (for the adult candidates or the parent/legal tutor of the pediatric candidates)
- Aged between 1 day and 21 years old (inclusively).
You will not qualify if you...
- History of another cancer in the past 5 years other than non-melanomatous skin cancer
- Currently under a randomized control trial with unknown allocation
- Currently under treatment
- Medical/surgical intervention on the tumour between 123I-MIBG and 68Ga-DOTATATE PET/CT scan
- Medically unstable or unable to undergo scan
- Pregnancy (breastfeeding is not an exclusion criterion but needs to be stopped for at least 12 hours after 68Ga-DOTATATE injection)
- Prior allergic reaction to somatostatin analogues
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
McGill University Health Center - Children's hospital
Montreal, Quebec, Canada, H4A 3J1
Withdrawn
2
CHU Ste-Justine
Montreal, Quebec, Canada, J1H 5N4
Actively Recruiting
3
CIUSSS de l'Estrie-CHUS Hospital
Sherbrooke, Quebec, Canada, J1H 5N4
Actively Recruiting
Research Team
A
Amelie Tetu, MSc
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here